Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > A combined GBM & NSCLC Phase 1b ?

<< Previous

Bullboard Posts

Next >>

Comment by Sunvalleyon Aug 30, 2022 9:16am

187 Views

Post# 34929108

RE:RE:RE:RE:RE:RE:A combined GBM & NSCLC Phase 1b ?

I hear you Goosey. My hunting partner,s son just died from it 3 months ago at a young age. Fingers and toes crossed while we wait. A cure or even a hint of one would reverberate around the world at warp speed.

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland